ShareHope Medicine Co., Ltd. (TPEX:8403)
29.10
+0.30 (1.04%)
At close: Feb 14, 2025
ShareHope Medicine Revenue
ShareHope Medicine had revenue of 1.15B TWD in the quarter ending September 30, 2024, with 18.65% growth. This brings the company's revenue in the last twelve months to 4.28B, up 14.71% year-over-year. In the year 2023, ShareHope Medicine had annual revenue of 3.87B, down -6.38%.
Revenue (ttm)
4.28B
Revenue Growth
+14.71%
P/S Ratio
0.89
Revenue / Employee
36.28M
Employees
118
Market Cap
3.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 3.87B | -263.75M | -6.38% |
Dec 31, 2022 | 4.14B | 287.10M | 7.46% |
Dec 31, 2021 | 3.85B | -248.85M | -6.07% |
Dec 31, 2020 | 4.10B | 974.99M | 31.21% |
Dec 31, 2019 | 3.12B | 66.56M | 2.18% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 8.32B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 16.71B |
Lotus Pharmaceutical | 17.59B |
Lumosa Therapeutics | 37.82M |
Oneness Biotech | 112.20M |
Polaris Group | 75.65M |
Pegavision | 7.06B |